Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gordon W. Dewald

Cytogenetic Prioritization With Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the US Intergroup Phase III Trial E2997

Leukemia and Lymphoma

English

Related publications

Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study

Clinical Lymphoma, Myeloma and Leukemia

English

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

Journal of Clinical Oncology

English

Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

Five‐year Survival Follow‐up of a Phase III Randomised Trial Comparing Ofatumumab Versus Physicians' Choice for Bulky Fludarabine‐refractory Chronic Lymphocytic Leukaemia: A Short Report

British Journal of Haematology

Hematology

2020

English

Ochroconis Gallopava Endophthalmitis in Fludarabine Treated Chronic Lymphocytic Leukaemia

British Journal of Ophthalmology

Molecular Neuroscience

English

Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Oncotarget

Oncology

2016

English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology

Hematology

2015

English

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology

English

Fatal CMV Pneumonia Associated With Steroid Therapy After Autologous Transplantation in Patients Previously Treated With Fludarabine

Bone Marrow Transplantation

Transplantation

Hematology

1998

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gordon W. Dewald

Cytogenetic Prioritization With Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the US Intergroup Phase III Trial E2997

Related publications

Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Five‐year Survival Follow‐up of a Phase III Randomised Trial Comparing Ofatumumab Versus Physicians' Choice for Bulky Fludarabine‐refractory Chronic Lymphocytic Leukaemia: A Short Report

Ochroconis Gallopava Endophthalmitis in Fludarabine Treated Chronic Lymphocytic Leukaemia

Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Fatal CMV Pneumonia Associated With Steroid Therapy After Autologous Transplantation in Patients Previously Treated With Fludarabine